- Prognostic utility of the 21-gene assay in hormone receptor-positive operable breast cancer compared with classical clinicopathologic features
[作者:Goldstein, LJ; Gray, R; Badve, S; Childs, BH; Yoshizawa, C; Rowley, S; Shak, S; Baehner, FL; Ravdin, PM; Davidson, NE; Sledge, GW; Perez, EA; Shulman, LN; Martino, S; Sparano, JA,期刊:Journal of clinical oncology, 页码:4063-4071 , 文章类型: Article,,卷期:2008年26-25]
- Purpose Adjuvant! is a standardized validated decision aid that projects outcomes in operable breast cancer based on classical clinicopathologic features and therapy. Genomic classifiers offer the potential to more accur...
- Screening for neurocognitive impairment in pediatric cancer long-term survivors
[作者:Krull, KR; Okcu, MF; Potter, B; Jain, N; Dreyer, Z; Kamdar, K; Brouwers, P,期刊:Journal of clinical oncology, 页码:4138-4143 , 文章类型: Article,,卷期:2008年26-25]
- Purpose Recent studies suggest that up to 40% of childhood cancer survivors may experience neurocognitive problems, a finding that has led the Children's Oncology Group to recommend regular evaluation. However, for a var...
- Predication of cancer patients' survival by pain interference items is not the same as evidence that pain intensity is a survival predictor - In reply
[作者:Halabi, S; Vogelzang, NJ; Kornblith, AB; Ou, SS; Kantoff, PW; Dawson, NA; Small, EJ,期刊:Journal of clinical oncology, 页码:4216-4217 , 文章类型: Letter,,卷期:2008年26-25]
-
- Mutations of KRAS and BRAF in primary and matched metastatic sites of colorectal cancer
[作者:Artale, S; Sartore-Bianchi, A; Veronese, SM; Gambi, V; Sarnataro, CS; Gambacorta, M; Lauricella, C; Siena, S,期刊:Journal of clinical oncology, 页码:4217-4219 , 文章类型: Letter,,卷期:2008年26-25]
-
- Detailed analysis of visitors to cancer-related web sites
[作者:Narimatsu, H; Matsumura, T; Morita, T; Kishi, Y; Yuji, K; Kami, M; Komatsu, T; Tanaka, Y; Sawa, T; Nakata, Y,期刊:Journal of clinical oncology, 页码:4219-4223 , 文章类型: Letter,,卷期:2008年26-25]
-
- Cetuximab pharmacokinetics in end-stage kidney disease under hemodialysis
[作者:Thariat, J; Azzopardi, N; Peyrade, F; Launay-Vacher, V; Santini, J; Lecomte, T; Etienne-Grimaldi, MC; Paintaud, G; Milano, G,期刊:Journal of clinical oncology, 页码:4223-4225 , 文章类型: Letter,,卷期:2008年26-25]
-
- Inhibition of imatinib transport by uremic toxins during renal failure - In reply
[作者:Egorin, M; Ramanathan, RK; Gibbons, J; Petros, W; Ivy, SP; Remick, SC,期刊:Journal of clinical oncology, 页码:4227-4228 , 文章类型: Letter,,卷期:2008年26-25]
-
- Expanding circle of inhibition: Small-molecule inhibitors of Bcl-2 as anticancer cell and antiangiogenic agents
[作者:Zeitlin, BD; Zeitlin, IJ; Nor, JE,期刊:Journal of clinical oncology, 页码:4180-4188 , 文章类型: Review,,卷期:2008年26-25]
- The specific targeting of diseases, particularly cancer, is a primary aim in drug development, as specificity reduces unwelcome effects on healthy tissue and increases drug efficacy at the target site. Drug specificity c...
- Impact of raloxifene or tamoxifen use on endometrial cancer risk: A population-based case-control study
[作者:DeMichele, A; Troxel, AB; Berlin, JA; Weber, AL; Bunin, GR; Turzo, E; Schinnar, R; Burgh, D; Berlin, M; Rubin, SC; Rebbeck, TR; Strom, BL,期刊:Journal of clinical oncology, 页码:4151-4159 , 文章类型: Article,,卷期:2008年26-25]
- Purpose Raloxifene reduces breast cancer risk in women with osteoporosis, and both tamoxifen and raloxifene prevent breast cancer in high-risk women. However, in vitro, raloxifene does not share the pro-estrogenic effect...
- Serous tubal Intraepithelial carcinoma: Its potential role in primary peritoneal serous carcinoma and serous cancer prevention
[作者:Carlson, JW; Miron, A; Jarboe, EA; Parast, MM; Hirsch, MS; Lee, YH; Muto, MG; Kindelberger, D; Crum, CP,期刊:Journal of clinical oncology, 页码:4160-4165 , 文章类型: Article,,卷期:2008年26-25]
- Purpose A diagnosis of primary peritoneal serous carcinoma (PPSC) requires exclusion of a source in other reproductive organs. Serous tubal intraepithelial carcinoma (STIC; stage 0) has been described in asymptomatic wom...
|